EW
Edwards Lifesciences Corporation
Medical Devices · Healthcare · United States
94.44
close · 2026-10-29
value
15
cheaper than peers15
quality
97
stronger fundamentals97
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 27.93× | 35 |
| price to book | 5.13× | 30 |
| EV to EBITDA | 22.48× | 23 |
| price to sales | 7.40× | 17 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 29.8% | 98 |
| debt to equity | 6.8% | 86 |
| revenue growth | 13.6% | 63 |
3 of 4 measures available
Facts
| market cap | $54B |
| free cash flow | — |
| employees | 16,000 |
| first trade | 2000-03-27 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-07-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 1.83 | 6.97 | 2.30 | 2.44 |
| free cash flow | $1.33B | $259.9M | $629.5M | $953.4M |
| net income | $1.07B | $4.17B | $1.40B | $1.52B |
| revenue | $6.07B | $5.44B | $5.01B | $4.46B |
| unusual items | -$514.9M | -$39.9M | -$168.0M | -$37.0M |